Details for: SDF2L1

Gene ID: 23753

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: SDF2L1

Ensembl ID: ENSG00000128228

Description: stromal cell derived factor 2 like 1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • plasmablast CL0000980
    CSI 83.11
    rCSI 65.38%
    PRS 62.11
  • IgA plasma cell CL0000987
    CSI 61.76
    rCSI 63.22%
    PRS 71.6
  • granulocyte monocyte progenitor cell CL0000557
    CSI 53.15
    rCSI 46.02%
    PRS 60.07
  • plasma cell CL0000786
    CSI 52.15
    rCSI 68.35%
    PRS 83.99
  • pancreatic A cell CL0000171
    CSI 42.84
    rCSI 44.88%
    PRS 58.63
  • common myeloid progenitor CL0000049
    CSI 42.08
    rCSI 34.03%
    PRS 56.61
  • IgG plasma cell CL0000985
    CSI 41.93
    rCSI 50.22%
    PRS 73.28
  • promyelocyte CL0000836
    CSI 41.21
    rCSI 59.44%
    PRS 65.15
  • intestine goblet cell CL0019031
    CSI 38.83
    rCSI 34.47%
    PRS 53.59
  • extravillous trophoblast CL0008036
    CSI 36.12
    rCSI 44.68%
    PRS 51.33
  • stem cell CL0000034
    CSI 24.42
    rCSI 23.54%
    PRS 45.83
  • pancreatic D cell CL0000173
    CSI 24.06
    rCSI 23.66%
    PRS 57.78
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 23.22
    rCSI 13.71%
    PRS 72.26
  • duct epithelial cell CL0000068
    CSI 21.16
    rCSI 30.96%
    PRS 59.28
  • tracheobronchial smooth muscle cell CL0019019
    CSI 20.74
    rCSI 36.57%
    PRS 63.7
  • goblet cell CL0000160
    CSI 20.26
    rCSI 19.14%
    PRS 55.22
  • myeloid leukocyte CL0000766
    CSI 20.24
    rCSI 18.67%
    PRS 56.51
  • promonocyte CL0000559
    CSI 16.62
    rCSI 28.48%
    PRS 64.74
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 16.12
    rCSI 14.9%
    PRS 75.35
  • IgM plasma cell CL0000986
    CSI 15.46
    rCSI 69.56%
    PRS 88.09
  • foveolar cell of stomach CL0002179
    CSI 15.4
    rCSI 32.78%
    PRS 67.92
  • transit amplifying cell CL0009010
    CSI 15.31
    rCSI 23.41%
    PRS 70.1
  • fibroblast of lung CL0002553
    CSI 14.61
    rCSI 13.59%
    PRS 55.26
  • vascular associated smooth muscle cell CL0000359
    CSI 14.59
    rCSI 47.32%
    PRS 56.83
  • small intestine goblet cell CL1000495
    CSI 13.92
    rCSI 30.48%
    PRS 64.02
  • placental villous trophoblast CL2000060
    CSI 13.53
    rCSI 20.91%
    PRS 53.41
  • pancreatic ductal cell CL0002079
    CSI 13.2
    rCSI 25.67%
    PRS 57.87
  • pancreatic acinar cell CL0002064
    CSI 13.11
    rCSI 17.43%
    PRS 60.96
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 12.93
    rCSI 8.62%
    PRS 77.24
  • paneth cell CL0000510
    CSI 12.48
    rCSI 18.43%
    PRS 71.85
  • mucous neck cell CL0000651
    CSI 11.69
    rCSI 16.85%
    PRS 66.95
  • double negative thymocyte CL0002489
    CSI 11.51
    rCSI 8%
    PRS 65.79
  • colon epithelial cell CL0011108
    CSI 11.29
    rCSI 11.83%
    PRS 52.13
  • type B pancreatic cell CL0000169
    CSI 11.15
    rCSI 24.68%
    PRS 53.17
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 10.3
    rCSI 9.38%
    PRS 69.72
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 10.21
    rCSI 29.29%
    PRS 74.86
  • mononuclear phagocyte CL0000113
    CSI 9.92
    rCSI 21.85%
    PRS 59.26
  • ciliated cell CL0000064
    CSI 9.9
    rCSI 16.05%
    PRS 52.63
  • respiratory suprabasal cell CL4033048
    CSI 9.54
    rCSI 12.24%
    PRS 60.28
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 9.54
    rCSI 12.24%
    PRS 52.86
  • endothelial cell of periportal hepatic sinusoid CL0019021
    CSI 9.42
    rCSI 43.22%
    PRS 68.98
  • Hofbauer cell CL3000001
    CSI 9.33
    rCSI 17.61%
    PRS 65.88
  • myofibroblast cell CL0000186
    CSI 9.15
    rCSI 12.67%
    PRS 57.75
  • bronchial goblet cell CL1000312
    CSI 9.15
    rCSI 36.56%
    PRS 73.24
  • megakaryocyte CL0000556
    CSI 8.73
    rCSI 37.89%
    PRS 69.46
  • pancreatic stellate cell CL0002410
    CSI 8.73
    rCSI 50.79%
    PRS 65.19
  • colon goblet cell CL0009039
    CSI 8.68
    rCSI 20.64%
    PRS 65.64
  • plasmacytoid dendritic cell, human CL0001058
    CSI 8.48
    rCSI 5.92%
    PRS 58.05
  • ciliated epithelial cell CL0000067
    CSI 8.46
    rCSI 7.44%
    PRS 43.62
  • hepatocyte CL0000182
    CSI 8.26
    rCSI 14.78%
    PRS 54.22
  • enteric smooth muscle cell CL0002504
    CSI 8.25
    rCSI 11.77%
    PRS 57.83
  • antibody secreting cell CL0000946
    CSI 8.25
    rCSI 36.67%
    PRS 89.61
  • pulmonary alveolar type 2 cell CL0002063
    CSI 8.18
    rCSI 12.68%
    PRS 63.32
  • alveolar macrophage CL0000583
    CSI 8.08
    rCSI 13.31%
    PRS 60.6
  • secretory cell CL0000151
    CSI 7.56
    rCSI 7.89%
    PRS 55.8
  • pulmonary capillary endothelial cell CL4028001
    CSI 7.32
    rCSI 13.97%
    PRS 71.08
  • bronchus fibroblast of lung CL2000093
    CSI 7.3
    rCSI 5.93%
    PRS 55.72
  • elicited macrophage CL0000861
    CSI 7.19
    rCSI 6.6%
    PRS 63.75
  • mesenchymal cell CL0008019
    CSI 7.1
    rCSI 18.03%
    PRS 50.07
  • inflammatory macrophage CL0000863
    CSI 7.08
    rCSI 12.1%
    PRS 79.99
  • luminal epithelial cell of mammary gland CL0002326
    CSI 6.97
    rCSI 12.67%
    PRS 71.36
  • memory T cell CL0000813
    CSI 6.65
    rCSI 12.8%
    PRS 82.6
  • enterocyte CL0000584
    CSI 6.63
    rCSI 10.69%
    PRS 60.57
  • glandular epithelial cell CL0000150
    CSI 6.56
    rCSI 17.26%
    PRS 75.34
  • tracheobronchial serous cell CL0019001
    CSI 6.52
    rCSI 28.19%
    PRS 69.2
  • mammary gland epithelial cell CL0002327
    CSI 6.5
    rCSI 22.8%
    PRS 68.98
  • epithelial cell of lung CL0000082
    CSI 6.48
    rCSI 5.37%
    PRS 54.22
  • keratinocyte CL0000312
    CSI 6.41
    rCSI 5.37%
    PRS 60.09
  • hematopoietic stem cell CL0000037
    CSI 6.27
    rCSI 4.17%
    PRS 58.85
  • Kupffer cell CL0000091
    CSI 6.12
    rCSI 13.99%
    PRS 54.86
  • T follicular helper cell CL0002038
    CSI 6.05
    rCSI 4.53%
    PRS 70.62
  • activated type II NK T cell CL0000931
    CSI 5.98
    rCSI 6.73%
    PRS 71.97
  • lung pericyte CL0009089
    CSI 5.97
    rCSI 15.76%
    PRS 63.91
  • epithelial cell of lower respiratory tract CL0002632
    CSI 5.85
    rCSI 4.53%
    PRS 56.65
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 5.74
    rCSI 5.65%
    PRS 78.76
  • perivascular cell CL4033054
    CSI 5.7
    rCSI 7.8%
    PRS 60.93
  • deuterosomal cell CL4033044
    CSI 5.67
    rCSI 19.16%
    PRS 61.28
  • epithelial cell CL0000066
    CSI 5.62
    rCSI 8.63%
    PRS 53.12
  • nasal mucosa goblet cell CL0002480
    CSI 5.6
    rCSI 6.5%
    PRS 63.99
  • group 3 innate lymphoid cell CL0001071
    CSI 5.54
    rCSI 4.16%
    PRS 60.16
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 5.45
    rCSI 4.09%
    PRS 83.8
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 5.34
    rCSI 4.27%
    PRS 76.39
  • enteroendocrine cell CL0000164
    CSI 5.3
    rCSI 7.24%
    PRS 57.5
  • basal cell CL0000646
    CSI 5.23
    rCSI 7%
    PRS 56.13
  • kidney epithelial cell CL0002518
    CSI 5.2
    rCSI 9.92%
    PRS 76.35
  • blood vessel endothelial cell CL0000071
    CSI 5.06
    rCSI 10.49%
    PRS 52.57
  • peptic cell CL0000155
    CSI 5.01
    rCSI 49.3%
    PRS 76.75
  • pulmonary ionocyte CL0017000
    CSI 4.94
    rCSI 6.01%
    PRS 63.13
  • multi-ciliated epithelial cell CL0005012
    CSI 4.9
    rCSI 4.89%
    PRS 48.89
  • Langerhans cell CL0000453
    CSI 4.86
    rCSI 7.42%
    PRS 71.86
  • P/D1 enteroendocrine cell CL0002268
    CSI 4.82
    rCSI 26.25%
    PRS 73.54
  • CD4-positive helper T cell CL0000492
    CSI 4.68
    rCSI 3.54%
    PRS 68.9
  • colon macrophage CL0009038
    CSI 4.64
    rCSI 21.41%
    PRS 75.24
  • fallopian tube secretory epithelial cell CL4030006
    CSI 4.63
    rCSI 4.46%
    PRS 55.74
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 4.61
    rCSI 6.04%
    PRS 68.88
  • glioblast CL0000030
    CSI 4.58
    rCSI 7.31%
    PRS 48.31
  • respiratory goblet cell CL0002370
    CSI 4.53
    rCSI 49.31%
    PRS 72.07
  • club cell CL0000158
    CSI 4.53
    rCSI 6.64%
    PRS 52.49
  • transit amplifying cell of colon CL0009011
    CSI 4.45
    rCSI 5.23%
    PRS 58.33
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 4.45
    rCSI 3.19%
    PRS 69.49
  • blood vessel smooth muscle cell CL0019018
    CSI 0.2
    rCSI 1.2%
    PRS 48.4%
  • epithelial cell of esophagus CL0002252
    CSI 0.2
    rCSI 1.6%
    PRS 75.8%
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 1.3%
    PRS 65.8%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 0.3
    rCSI 4.8%
    PRS 75.6%
  • paneth cell of colon CL0009009
    CSI 0.3
    rCSI 3.3%
    PRS 75.4%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.4
    rCSI 2.6%
    PRS 76.1%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.5
    rCSI 11.0%
    PRS 76.2%
  • primitive red blood cell CL0002355
    CSI 0.6
    rCSI 3.2%
    PRS 68.9%
  • large pre-B-II cell CL0000957
    CSI 0.6
    rCSI 1.8%
    PRS 68.5%
  • germinal center B cell CL0000844
    CSI 0.6
    rCSI 1.9%
    PRS 74.7%
  • podocyte CL0000653
    CSI 0.6
    rCSI 2.8%
    PRS 54.5%
  • basophil mast progenitor cell CL0002028
    CSI 0.7
    rCSI 3.5%
    PRS 87.8%
  • forebrain radial glial cell CL0013000
    CSI 0.7
    rCSI 2.1%
    PRS 61.4%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.7
    rCSI 1.7%
    PRS 45.0%
  • endothelial cell of placenta CL0009092
    CSI 0.7
    rCSI 3.4%
    PRS 66.8%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.8
    rCSI 3.6%
    PRS 85.0%
  • basophil CL0000767
    CSI 0.8
    rCSI 1.7%
    PRS 74.1%
  • BEST4+ enteroycte CL4030026
    CSI 0.9
    rCSI 1.1%
    PRS 57.3%
  • pancreatic epsilon cell CL0005019
    CSI 0.9
    rCSI 4.2%
    PRS 74.3%
  • mature alpha-beta T cell CL0000791
    CSI 0.9
    rCSI 3.3%
    PRS 75.2%
  • epithelial cell of urethra CL1000296
    CSI 0.9
    rCSI 23.1%
    PRS 75.7%
  • fraction A pre-pro B cell CL0002045
    CSI 1.0
    rCSI 1.1%
    PRS 76.0%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 1.0
    rCSI 2.8%
    PRS 63.1%
  • intestinal tuft cell CL0019032
    CSI 1.0
    rCSI 1.6%
    PRS 59.9%
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 1.1
    rCSI 3.3%
    PRS 65.4%
  • class switched memory B cell CL0000972
    CSI 1.1
    rCSI 0.8%
    PRS 73.0%
  • common lymphoid progenitor CL0000051
    CSI 1.1
    rCSI 1.4%
    PRS 77.6%
  • intermediate monocyte CL0002393
    CSI 1.1
    rCSI 1.6%
    PRS 58.6%
  • intestinal crypt stem cell of colon CL0009043
    CSI 1.1
    rCSI 8.6%
    PRS 73.0%
  • neuroendocrine cell CL0000165
    CSI 1.2
    rCSI 4.6%
    PRS 71.0%
  • pro-T cell CL0000827
    CSI 1.3
    rCSI 29.0%
    PRS 94.5%
  • lung secretory cell CL1000272
    CSI 1.3
    rCSI 3.1%
    PRS 53.3%
  • centrilobular region hepatocyte CL0019029
    CSI 1.3
    rCSI 3.4%
    PRS 60.8%
  • retinal cone cell CL0000573
    CSI 1.3
    rCSI 2.2%
    PRS 45.3%
  • T-helper 1 cell CL0000545
    CSI 1.4
    rCSI 2.4%
    PRS 78.9%
  • vein endothelial cell of respiratory system CL4033008
    CSI 1.4
    rCSI 9.5%
    PRS 70.1%
  • conjunctival epithelial cell CL1000432
    CSI 1.4
    rCSI 2.2%
    PRS 56.0%
  • tracheal goblet cell CL1000329
    CSI 1.4
    rCSI 3.1%
    PRS 71.3%
  • late pro-B cell CL0002048
    CSI 1.7
    rCSI 4.3%
    PRS 82.2%
  • paneth cell of epithelium of small intestine CL1000343
    CSI 1.7
    rCSI 4.8%
    PRS 68.0%
  • colonocyte CL1000347
    CSI 1.8
    rCSI 2.5%
    PRS 60.3%
  • lung ciliated cell CL1000271
    CSI 1.8
    rCSI 2.1%
    PRS 45.2%
  • peripheral nervous system neuron CL2000032
    CSI 1.9
    rCSI 2.5%
    PRS 47.7%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 1.9
    rCSI 3.6%
    PRS 75.2%
  • erythroid progenitor cell CL0000038
    CSI 1.9
    rCSI 10.9%
    PRS 65.5%
  • intraepithelial lymphocyte CL0002496
    CSI 1.9
    rCSI 5.2%
    PRS 86.4%
  • ionocyte CL0005006
    CSI 1.9
    rCSI 2.1%
    PRS 54.1%
  • lung endothelial cell CL1001567
    CSI 2.0
    rCSI 4.5%
    PRS 76.1%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.0
    rCSI 3.0%
    PRS 80.6%
  • erythroid lineage cell CL0000764
    CSI 2.0
    rCSI 12.6%
    PRS 74.8%
  • basal cell of prostate epithelium CL0002341
    CSI 2.0
    rCSI 5.7%
    PRS 69.6%
  • immature B cell CL0000816
    CSI 2.0
    rCSI 1.5%
    PRS 69.2%
  • cerebral cortex endothelial cell CL1001602
    CSI 2.0
    rCSI 3.5%
    PRS 45.5%
  • small pre-B-II cell CL0000954
    CSI 2.1
    rCSI 2.0%
    PRS 78.4%
  • hepatic stellate cell CL0000632
    CSI 2.1
    rCSI 7.8%
    PRS 47.6%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.2
    rCSI 2.6%
    PRS 75.4%
  • mesodermal cell CL0000222
    CSI 2.2
    rCSI 2.7%
    PRS 53.6%
  • interstitial cell of Cajal CL0002088
    CSI 2.2
    rCSI 2.9%
    PRS 61.7%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.3
    rCSI 2.3%
    PRS 68.8%
  • mature B cell CL0000785
    CSI 2.3
    rCSI 2.0%
    PRS 66.0%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.4
    rCSI 1.6%
    PRS 67.9%
  • early lymphoid progenitor CL0000936
    CSI 2.5
    rCSI 2.2%
    PRS 60.6%
  • mature T cell CL0002419
    CSI 2.5
    rCSI 2.0%
    PRS 73.2%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.5
    rCSI 1.9%
    PRS 55.1%
  • serous secreting cell CL0000313
    CSI 2.5
    rCSI 12.8%
    PRS 83.0%
  • brush cell CL0002204
    CSI 2.5
    rCSI 5.0%
    PRS 75.0%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 2.6
    rCSI 5.9%
    PRS 52.5%
  • retinal blood vessel endothelial cell CL0002585
    CSI 2.7
    rCSI 4.2%
    PRS 59.3%
  • luminal cell of prostate epithelium CL0002340
    CSI 2.7
    rCSI 14.5%
    PRS 68.8%
  • enteroendocrine cell of small intestine CL0009006
    CSI 2.7
    rCSI 6.0%
    PRS 68.7%
  • periportal region hepatocyte CL0019026
    CSI 2.7
    rCSI 10.6%
    PRS 61.9%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 2.8
    rCSI 3.3%
    PRS 45.2%
  • acinar cell CL0000622
    CSI 2.8
    rCSI 4.1%
    PRS 66.9%
  • respiratory hillock cell CL4030023
    CSI 2.8
    rCSI 5.0%
    PRS 69.7%
  • neural progenitor cell CL0011020
    CSI 2.8
    rCSI 12.2%
    PRS 46.9%
  • thymocyte CL0000893
    CSI 2.8
    rCSI 10.0%
    PRS 86.8%
  • M cell of gut CL0000682
    CSI 2.9
    rCSI 3.1%
    PRS 67.3%
  • intestinal epithelial cell CL0002563
    CSI 2.9
    rCSI 3.1%
    PRS 53.8%
  • myeloid dendritic cell CL0000782
    CSI 3.0
    rCSI 4.3%
    PRS 71.4%
  • T-helper 17 cell CL0000899
    CSI 3.0
    rCSI 2.4%
    PRS 77.4%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 3.1
    rCSI 4.2%
    PRS 80.9%
  • alveolar adventitial fibroblast CL4028006
    CSI 3.1
    rCSI 4.9%
    PRS 56.9%
  • natural T-regulatory cell CL0000903
    CSI 3.2
    rCSI 6.0%
    PRS 85.8%
  • radial glial cell CL0000681
    CSI 3.2
    rCSI 4.5%
    PRS 54.3%
  • lung neuroendocrine cell CL1000223
    CSI 3.2
    rCSI 4.8%
    PRS 60.7%
  • type L enteroendocrine cell CL0002279
    CSI 3.3
    rCSI 6.2%
    PRS 72.4%
  • pre-conventional dendritic cell CL0002010
    CSI 3.3
    rCSI 43.6%
    PRS 84.2%
  • CD14-positive monocyte CL0001054
    CSI 3.3
    rCSI 4.1%
    PRS 66.1%
  • dendritic cell, human CL0001056
    CSI 3.4
    rCSI 5.2%
    PRS 63.9%
  • renal alpha-intercalated cell CL0005011
    CSI 3.4
    rCSI 4.5%
    PRS 64.4%
  • skin fibroblast CL0002620
    CSI 3.4
    rCSI 2.9%
    PRS 61.8%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 3.5
    rCSI 3.1%
    PRS 52.2%
  • common dendritic progenitor CL0001029
    CSI 3.5
    rCSI 4.3%
    PRS 65.7%
  • alternatively activated macrophage CL0000890
    CSI 3.5
    rCSI 4.4%
    PRS 68.0%
  • type EC enteroendocrine cell CL0000577
    CSI 3.6
    rCSI 12.9%
    PRS 65.7%
  • lung macrophage CL1001603
    CSI 3.7
    rCSI 8.2%
    PRS 62.9%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 3.7
    rCSI 3.6%
    PRS 71.2%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 3.7
    rCSI 10.7%
    PRS 57.1%
  • syncytiotrophoblast cell CL0000525
    CSI 3.8
    rCSI 10.8%
    PRS 70.5%
  • respiratory basal cell CL0002633
    CSI 3.8
    rCSI 3.9%
    PRS 61.0%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [SDF2L1](/details-gene/23753) (Stromal Cell Derived Factor 2 Like 1) is a protein-coding gene located on chromosome 22q11.21. It encodes a protein that resides within the endoplasmic reticulum lumen and functions as a chaperone-binding protein. Its primary role is associated with the cellular response to misfolded proteins and the endoplasmic reticulum-associated degradation (ERAD) pathway. Expression data indicates that [SDF2L1](/details-gene/23753) is a highly significant gene in professional secretory cells, particularly those of the immune system such as `[plasmablast](/details-cell/CL0000980)`s and `[plasma cell](/details-cell/CL0000786)`s, suggesting a crucial function in managing the high protein folding load required for antibody production. ## Cellular Roles and Expression Landscape The expression profile of [SDF2L1](/details-gene/23753) highlights its specialized role in cells with high secretory capacity. **Overall**, the gene shows the highest significance in terminally differentiated B-lineage cells, including `[plasmablast](/details-cell/CL0000980)` (CSI: 83.11), `[IgA plasma cell](/details-cell/CL0000987)` (CSI: 61.76), and `[IgG plasma cell](/details-cell/CL0000985)` (CSI: 41.93). This strong association suggests that [SDF2L1](/details-gene/23753) is a key component of the cellular machinery that supports the massive synthesis and secretion of immunoglobulins. Its significance extends to hematopoietic progenitors, such as `[granulocyte monocyte progenitor cell](/details-cell/CL0000557)` and `[common myeloid progenitor](/details-cell/CL0000049)`, which may indicate a role in preparing these cells for differentiation into active effector lineages. Beyond the immune system, [SDF2L1](/details-gene/23753) is also significantly expressed in other highly secretory cell types. These include hormone-producing `[pancreatic A cell](/details-cell/CL0000171)`s, mucus-producing `[intestine goblet cell](/details-cell/CL0019031)`s, and `[extravillous trophoblast](/details-cell/CL0008036)`s, which are involved in placental hormone secretion. This consistent pattern across functionally diverse secretory cells reinforces its fundamental role in managing proteostasis within the endoplasmic reticulum. ## Pathways and Molecular Function Functional annotations are highly consistent with the observed cellular expression pattern of [SDF2L1](/details-gene/23753). The gene product is localized to the `[endoplasmic reticulum](/details-cell/GO:0005783)`, specifically within the `[endoplasmic reticulum lumen](/details-cell/GO:0005788)` and as part of the `[endoplasmic reticulum chaperone complex](/details-cell/GO:0034663)`. Its molecular functions are centered on protein quality control, including `[misfolded protein binding](/details-cell/GO:0051787)` and `[protein-folding chaperone binding](/details-cell/GO:0051087)`. These functions are critical for biological processes such as the `[cellular response to misfolded protein](/details-cell/GO:0071218)` and the `[ERAD pathway](/details-cell/GO:0036503)`, which ensures that improperly folded proteins are targeted for degradation rather than accumulating to toxic levels. Research has confirmed that [SDF2L1](/details-gene/23753) is an ER stress-inducible gene and that its protein product is part of multiprotein complexes that bind to nascent proteins, underscoring its role in the early stages of protein folding and quality control ([Link](https://pubmed.ncbi.nlm.nih.gov/11162531/), [Link](https://pubmed.ncbi.nlm.nih.gov/12475965/)). This involvement is essential for the survival and function of cells like `[plasma cell](/details-cell/CL0000786)`s, which operate under constant ER stress due to high-volume protein synthesis. ## Research Directions The specific and high-level expression of [SDF2L1](/details-gene/23753) in cells defined by intense secretory activity suggests it could be a critical node in both normal physiology and diseases characterized by proteotoxic stress. ### Proposed Hypotheses: 1. **Role in Plasma Cell Dyscrasias:** Given its high significance in `[plasma cell](/details-cell/CL0000786)`s, dysregulation of [SDF2L1](/details-gene/23753) may be a key factor in the pathogenesis or therapeutic response of plasma cell malignancies like multiple myeloma. Overexpression could be a pro-survival mechanism allowing cancer cells to cope with the immense ER stress from monoclonal immunoglobulin production, while its inhibition could represent a therapeutic vulnerability. 2. **Function in Endocrine Pathologies:** The notable expression in `[pancreatic A cell](/details-cell/CL0000171)`s suggests [SDF2L1](/details-gene/23753) is important for the proper folding and secretion of glucagon. Genetic or functional deficiencies in [SDF2L1](/details-gene/23753) could contribute to ER stress-induced apoptosis of alpha cells, potentially impacting glucose homeostasis and contributing to endocrine disorders. ### Suggested Experimental Approach: To test the first hypothesis regarding its role in multiple myeloma, a combination of genetic and pharmacological approaches could be employed. Specifically, one could use CRISPR-Cas9 to knock out [SDF2L1](/details-gene/23753) in multiple myeloma cell lines that are dependent on high immunoglobulin production. The resulting cellular phenotype could be assessed via assays for cell viability, apoptosis (e.g., Annexin V staining), and proliferation. Furthermore, the molecular consequences could be measured by quantifying the activation of key unfolded protein response (UPR) pathways (e.g., phosphorylation of PERK, splicing of XBP1) and by determining if the loss of [SDF2L1](/details-gene/23753) sensitizes these cells to treatment with proteasome inhibitors such as bortezomib. ### Therapeutic Potential: As an intracellular protein located in the endoplasmic reticulum, [SDF2L1](/details-gene/23753) is not a conventional target for antibody-based therapies. However, its crucial role in managing proteotoxic stress in specific cancers makes it an attractive candidate for small molecule inhibitor development. Cancers like multiple myeloma are highly dependent on the UPR to survive, a phenomenon known as "ER stress addiction." **Inhibition** of [SDF2L1](/details-gene/23753) function could disrupt this coping mechanism, leading to intolerable levels of ER stress and inducing selective apoptosis in malignant `[plasma cell](/details-cell/CL0000786)`s. Such a strategy could be used as a monotherapy or, more likely, in combination with existing drugs like proteasome inhibitors to achieve synergistic anti-cancer effects.

Genular Protein ID: 669395550

Symbol: SDF2L_HUMAN

Name: Stromal cell-derived factor 2-like protein 1

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11162531

Title: Murine and human SDF2L1 is an endoplasmic reticulum stress-inducible gene and encodes a new member of the Pmt/rt protein family.

PubMed ID: 11162531

DOI: 10.1006/bbrc.2000.4111

PubMed ID: 12975309

Title: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

PubMed ID: 12975309

DOI: 10.1101/gr.1293003

PubMed ID: 15461802

Title: A genome annotation-driven approach to cloning the human ORFeome.

PubMed ID: 15461802

DOI: 10.1186/gb-2004-5-10-r84

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 12475965

Title: A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins.

PubMed ID: 12475965

DOI: 10.1091/mbc.e02-05-0311

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

Sequence Information:

  • Length: 221
  • Mass: 23598
  • Checksum: D6F15E1EB48428EE
  • Sequence:
  • MWSAGRGGAA WPVLLGLLLA LLVPGGGAAK TGAELVTCGS VLKLLNTHHR VRLHSHDIKY 
    GSGSGQQSVT GVEASDDANS YWRIRGGSEG GCPRGSPVRC GQAVRLTHVL TGKNLHTHHF 
    PSPLSNNQEV SAFGEDGEGD DLDLWTVRCS GQHWEREAAV RFQHVGTSVF LSVTGEQYGS 
    PIRGQHEVHG MPSANTHNTW KAMEGIFIKP SVEPSAGHDE L